PF-02341066
A8081007
Phase 3 small_molecule completed
Quick answer
PF-02341066 for Carcinoma, Non-Small-Cell Lung is a Phase 3 program (small_molecule) at Pfizer with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed